Know Cancer

or
forgot password

Study of New Adjuvant Chemotherapy of Non Resectable Liver Metastasis of Colorectal Cancer Without Bleeding, Obstruction


Phase 4
18 Years
75 Years
Open (Enrolling)
Both
Colorectal Neoplasms, Neoplasm Metastasis, Liver Neoplasms, Chemotherapy; Maternal, Affecting Fetus

Thank you

Trial Information

Study of New Adjuvant Chemotherapy of Non Resectable Liver Metastasis of Colorectal Cancer Without Bleeding, Obstruction


Inclusion Criteria:



- age between 18 - 75 years old

- colorectal adenocarcinoma pathologically

- without any chemotherapy or radiotherapy

- unresectable liver metastasis and without other metastasis

- resectable colorectal cancer

- suitable for chemotherapy

- agreed by patients

Exclusion Criteria:

- age below 18 years old or greater than 75 years old

- haven't pathological diagnosis of colorectal adenocarcinoma

- with any chemotherapy or radiotherapy

- resectable liver metastasis or without other metastasis

- unresectable colorectal cancer

- unsuitable for chemotherapy

- not agreed by patients

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

liver metastasis resection rate

Outcome Time Frame:

3 years

Safety Issue:

Yes

Authority:

China: Food and Drug Administration

Study ID:

20110101

NCT ID:

NCT01307878

Start Date:

January 2011

Completion Date:

December 2015

Related Keywords:

  • Colorectal Neoplasms
  • Neoplasm Metastasis
  • Liver Neoplasms
  • Chemotherapy; Maternal, Affecting Fetus
  • Neoplasms
  • Colorectal Neoplasms
  • Hemorrhage
  • Liver Neoplasms
  • Neoplasm Metastasis
  • Neoplasms, Second Primary

Name

Location